IP Library › Assignment 033178/0558
Patent Assignment
Reel/Frame 033178/0558

Assignment of Assignor's Interest

Recorded: 2014-06-10 Pages: 5
Assignor
THERAVANCE, INC.
Executed: 2014-05-31
Assignee
THERAVANCE RESPIRATORY COMPANY, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (3)
Compounds Having Beta Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,569,586 →
Application: 11/204,263 →
Publication: US 2006/0035933
Method of Using Compounds Having Beta-2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 8,143,277 →
Application: 12/479,017 →
Publication: US 2009/0239904
Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
Application: 60/601,779 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 11, 2004
From: MAMMEN, MATHAI; MISCHKI, TREVOR
To: THERAVANCE, INC.
Reel/Frame 015372/0152 →
Assignment of Assignor's Interest Oct 26, 2005
From: MAMMEN, MATHAI; MISCHKI, TREVOR; HUGHES, ADAM; JI, YU-HUA
To: THERAVANCE, INC.
Reel/Frame 016943/0092 →
Assignment of Assignor's Interest Nov 12, 2020
From: THERAVANCE RESPIRATORY COMPANY, LLC
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 054393/0695 →